News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022
News Daily News Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR Caitlin E. Cox February 22, 2022
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021
News Daily News Outcomes Worse With Combined Transcatheter Aortic, Mitral Procedures Todd Neale July 07, 2021
News Daily News New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR Caitlin E. Cox December 23, 2020
News Daily News US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends Caitlin E. Cox November 17, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Conference News TCT 2020 MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions Shelley Wood October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Daily News Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights Yael L. Maxwell February 28, 2020
News Daily News Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes Todd Neale February 18, 2020
News Daily News MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR Michael O'Riordan February 13, 2020
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
Presentation Cardiovascular Interventions 2019 Transcatheter Mitral Repair and Replacement: Data, Devices, and Patient Selection Presenter: Matthew J. Price November 01, 2019
News Conference News TCT 2019 MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis Shelley Wood September 29, 2019